Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Marion Pasin"'
Autor:
Helen Ashwin, Jovana Sadlova, Barbora Vojtkova, Tomas Becvar, Patrick Lypaczewski, Eli Schwartz, Elizabeth Greensted, Katrien Van Bocxlaer, Marion Pasin, Kai S. Lipinski, Vivak Parkash, Greg Matlashewski, Alison M. Layton, Charles J. Lacey, Charles L. Jaffe, Petr Volf, Paul M. Kaye
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
Controlled human infection models (CHIMs) provide a pathway for accelerating vaccine development. Here, the authors describe the isolation, characterization, and GMP manufacture of a clinical Leishmania major strain to be used as a resource for CHIM
Externí odkaz:
https://doaj.org/article/ddd377d986694040985714870d5c4e1c
Autor:
Simon Paris, Ludivine Chapat, Marion Pasin, Manon Lambiel, Thomas E. Sharrock, Rishabh Shukla, Cecile Sigoillot-Claude, Jeanne-Marie Bonnet, Hervé Poulet, Ludovic Freyburger, Karelle De Luca
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Several observations in the world of comparative immunology in plants, insects, fish and eventually mammals lead to the discovery of trained immunity in the early 2010's. The first demonstrations provided evidence that innate immune cells were capabl
Externí odkaz:
https://doaj.org/article/fc106f6c1823436ca66b76972d314dc6
Autor:
Greg Matlashewski, Petr Volf, Elizabeth Greensted, Tomas Becvar, Vivak Parkash, Patrick Lypaczewski, Eli Schwartz, Charles J.N. Lacey, Marion Pasin, Jovana Sadlova, Paul M. Kaye, Helen Ashwin, Kai S. Lipinski, Charles L. Jaffe, Katrien Van Bocxlaer, Alison M. Layton, Barbora Vojtkova
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
Nature Communications
Nature Communications
Leishmaniasis is widely regarded as a vaccine-preventable disease, but the costs required to reach pivotal Phase 3 studies and uncertainty about which candidate vaccines should be progressed into human studies significantly limits progress in vaccine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29b46a0997b8a6d091c7eaa2560b5038
https://doi.org/10.1038/s41467-020-20569-3
https://doi.org/10.1038/s41467-020-20569-3
Autor:
Jeanne-Marie Bonnet, Thomas E Sharrock, Ludovic Freyburger, Marion Pasin, Hervé Poulet, Simon Paris, Karelle De Luca, Cecile Sigoillot-Claude, Ludivine Chapat, Manon Lambiel, Rishabh Shukla
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 11 (2020)
Frontiers in Immunology, Vol 11 (2020)
Several observations in the world of comparative immunology in plants, insects, fish and eventually mammals lead to the discovery of trained immunity in the early 2010's. The first demonstrations provided evidence that innate immune cells were capabl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acce9d9d23e4fe3028bccfca3066bd70
http://europepmc.org/articles/PMC7581789
http://europepmc.org/articles/PMC7581789
Autor:
Elizabeth Greensted, Paul M. Kaye, Petr Volf, Helen Ashwin, Eli Schwartz, Barbora Vojtkova, Charles J.N. Lacey, Marion Pasin, Tomas Becvar, Alison M. Layton, Kai S. Lipinski, Greg Matlashewski, Vivak Parkash, Charles L. Jaffe, Patrick Lypaczewski, Katrien Van Bocxlaer, Jovana Sadlova
Leishmaniasis is widely regarded as a vaccine-preventable disease, but the costs required to reach pivotal Phase 3 studies and uncertainty about which candidate vaccines should be progressed into human studies significantly limits progress in vaccine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26829e33325cdfe420eb15ac1b434281
https://doi.org/10.1101/2020.08.12.245936
https://doi.org/10.1101/2020.08.12.245936
Autor:
Marion Pasin, Neann Mathai, Christin Walther, Núria Verdaguer, Dieter Blaas, Thomas C. Marlovits, Nikolaus Goessweiner-Mohr, Martina Richter, Jiri Wald, Irene Zanella, Antonio Real-Hohn, Vadim Makarov, Johannes Kirchmair, Michaela Schmidtke
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Proceedings of the National Academy of Sciences
instname
Proceedings of the National Academy of Sciences
Viral inhibitors, such as pleconaril and vapendavir, target conserved regions in the capsids of rhinoviruses (RVs) and enteroviruses (EVs) by binding to a hydrophobic pocket in viral capsid protein 1 (VP1). In resistant RVs and EVs, bulky residues in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78b62a3f049814336ba2e0765f1f1436
http://hdl.handle.net/10261/201423
http://hdl.handle.net/10261/201423